SPROSpero Therapeutics, Inc.Aug 12, 2026Q2 2026
Read transcript →Spero Therapeutics, Inc. (SPRO) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$1.14
+1.34%
Mkt Cap $70.64M
SPROSpero Therapeutics, Inc.Aug 12, 2026SPROSpero Therapeutics, Inc.Aug 12, 2025Q2 2025
Read transcript →SPROSpero Therapeutics, Inc.Mar 27, 2025Q4 2024
Read transcript →SPROSpero Therapeutics, Inc.Aug 9, 2024Q2 2024
Read transcript →SPROSpero Therapeutics, Inc.Mar 13, 2024Q4 2023
Read transcript →SPROSpero Therapeutics, Inc.Nov 13, 2023Q3 2023
Read transcript →SPROSpero Therapeutics, Inc.Aug 10, 2023Q2 2023
Read transcript →SPROSpero Therapeutics, Inc.May 11, 2023Q1 2023
Read transcript →SPROSpero Therapeutics, Inc.Mar 30, 2023Q4 2022
Read transcript →SPROSpero Therapeutics, Inc.Nov 14, 2022Q3 2022
Read transcript →SPROSpero Therapeutics, Inc.Aug 11, 2022Q2 2022
Read transcript →SPROSpero Therapeutics, Inc.May 16, 2022Q1 2022
Read transcript →SPROSpero Therapeutics, Inc.Mar 31, 2022Q4 2021
Read transcript →SPROSpero Therapeutics, Inc.Nov 10, 2021Q3 2021
Read transcript →SPROSpero Therapeutics, Inc.Aug 7, 2021Q2 2021
Read transcript →SPROSpero Therapeutics, Inc.May 9, 2021Q1 2021
Read transcript →SPROSpero Therapeutics, Inc.Mar 11, 2021Q4 2020
Read transcript →SPROSpero Therapeutics, Inc.Nov 7, 2020Q3 2020
Read transcript →SPROSpero Therapeutics, Inc.Aug 8, 2020Q2 2020
Read transcript →SPROSpero Therapeutics, Inc.May 12, 2020Q1 2020
Read transcript →